Emerson delivered a solid QQ2 2025 with revenue of $4.432 billion, gross margin of 53.5%, and adjusted EBITDA margin of 28%, marking record profitability for the period. Underlying orders grew 4% year over year, led by Process and Hybrid (up ~6%) and a return to positive momentum in Discrete (Test and Measurement up 8%). Management highlighted a favorable backdrop in LNG, life sciences, and energy transitions, while signaling continued resilience in MRO-driven demand. The company completed the AspenTech buy-in mid-quarter (ownership ~57%), positioning Emerson to push toward double-digit ACV growth and stronger software-automation synergies. However, Emerson faces tariff headwinds estimated at roughly $245 million on a gross annual basis for 2025 (about 2.5% of sales), which management expects to be offset through price actions and manufacturing regionalization, with a plan to fully offset headwinds in 2025 and carry benefits into 2026. The 2025 guidance remains attractive: underlying sales growth ~4%, adjusted EPS $5.90–$6.05, free cash flow of $3.1–$3.2 billion, and a continued commitment to capital returns. The following analysis integrates the QQ2 numbers, transcript insights, and competitive context to assess Emerson’s growth trajectory, profitability, balance sheet health, and investment appeal for the period ahead.